. . . . . . . . . . . . . . "m(HGNC:MIR21) -| r(HGNC:BTG2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Subsequently, a new target gene of miR-21, BTG2, was found to be downregulated in laryngeal carcinoma tissues. BTG2 is known to act as a pan-cell cycle regulator and tumor suppressor." . . "Selventa" . . . . "2014-07-03T14:30:54.867+02:00"^^ . . .